about
Elevated activity of phospholipid biosynthetic enzymes in substantia nigra of patients with Parkinson's disease.Single and binge methamphetamine administrations have different effects on the levels of dopamine D2 autoreceptor and dopamine transporter in rat striatum.Amphetamine toxicities: classical and emerging mechanisms.Co-administration of betulinic acid and methamphetamine causes toxicity to dopaminergic and serotonergic nerve terminals in the striatum of late adolescent ratsNeurotoxic Doses of Chronic Methamphetamine Trigger Retrotransposition of the Identifier Element in Rat Dorsal Dentate GyrusMethamphetamine oxidatively damages parkin and decreases the activity of 26S proteasome in vivo.Decreased activity of brain phospholipid metabolic enzymes in human users of cocaine and methamphetamine.Why is parkinsonism not a feature of human methamphetamine users?Regulation of dopamine D1 receptor function by physical interaction with the NMDA receptors.Characterization of Dopaminergic System in the Striatum of Young Adult Park2-/- Knockout Rats.Differential alteration of phospholipase A2 activities in brain of patients with schizophrenia.Rat striatal levels of the antioxidant glutathione are decreased following binge administration of methamphetamine.Low activity of key phospholipid catabolic and anabolic enzymes in human substantia nigra: possible implications for Parkinson's disease.The effect of transposon Pokey insertions on sequence variation in the 28S rRNA gene of Daphnia pulexGeneration and characterization of antibodies to adhesion-related molecules of retinal pigment epithelial cellsDifferential Responses of LINE-1 in the Dentate Gyrus, Striatum and Prefrontal Cortex to Chronic Neurotoxic Methamphetamine: A Study in Rat Brain
P50
Q31966978-3D239050-BD50-4141-85B6-1F39270783A4Q33580523-24B51668-9708-4301-8D16-A5571A9E886CQ34102002-69A8CB2F-E546-4133-A024-F1F8137DB9B4Q34428204-5B554BD0-9372-434F-BDAC-C1E51016ADE2Q37724118-CAEEBFBB-0DDD-49C4-AD6A-6851F88419C3Q39377116-6CA410FE-01AC-4F8B-BFAA-C480C906B177Q44026544-953A2A68-97A3-4540-A884-275FB8B118BEQ44673936-E9D2E4D2-A988-4D18-9748-E8872C947315Q44755344-292E569F-4771-45AD-9948-C3578D458331Q48171776-7687EB2E-F66C-4B5B-939B-DC1BA4BCE8B2Q48271291-15C22C30-9BE9-41E3-AA5B-D8309ABE48E3Q48336471-F8E07A83-6A97-4A2E-AE72-0A709270FF75Q48522703-27F611D0-7FFE-4DCA-84B5-1DFC01FD9273Q59888675-CD565A15-8BDD-486D-A420-CA31275A9C67Q72716245-6A1F1F85-6F97-4555-A3E8-D91807B90FEBQ90774801-0C68F13B-9CD6-46EB-A45E-C4BB623C9923
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Anna Moszczynska
@ast
Anna Moszczynska
@en
Anna Moszczynska
@es
Anna Moszczynska
@nl
type
label
Anna Moszczynska
@ast
Anna Moszczynska
@en
Anna Moszczynska
@es
Anna Moszczynska
@nl
prefLabel
Anna Moszczynska
@ast
Anna Moszczynska
@en
Anna Moszczynska
@es
Anna Moszczynska
@nl
P1053
I-6997-2013
P106
P1153
6601908444
P31
P496
0000-0002-9927-2318